Takeda Targets Rival Over Generic Diabetes Drug
By Vin Gurrieri ( November 21, 2011, 5:03 PM EST) -- Takeda Pharmaceutical Co. Ltd. launched its latest attack Wednesday in New York federal court seeking to prevent generic-drug maker Hetero Drugs Ltd. and several subsidiaries from producing their own version of the blockbuster diabetes drug Actos....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.